Abpro Holdings, Inc.

Abpro Holdings, Inc. (Nasdaq: ACAB) is a blank check company formed to pursue a merger, capital stock exchange, asset acquisition, or similar business combination. The company filed a Form 10-Q with the SEC on August 11, 2022, reflecting its status as an active SPAC in the search phase. Abpro Holdings targets opportunities in the life sciences and biotechnology sectors, consistent with its branding and management focus on biopharmaceutical innovation. The company went public in 2021. Detailed financial statements, SEC filing history, and target-search updates for ACAB are available on SpacDesk — sign up at SpacDesk.com for full data access and real-time SPAC monitoring.